http://qrxpharma.com/download/file/cp/QRxPharma_Investor_Deck_March_2014_Final_(14_March_2014).pdf
Page 9 demonstrates the safety advantages of moxduo over either morphine or oxycodone. These are findings from Study 022 which is what the AdCom will be discussing.
- Forums
- ASX - By Stock
- QRX
- palms are sweaty
palms are sweaty, page-23
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)